Search Results 1661-1670 of 20033 for Receptor
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to ...
A courageous mind, and a research career in the making featured image · Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-.
... receptor II (TGF-βRII). A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination ...
The disorder is primarily caused by a mutation in a receptor gene for low-density lipoprotein (LDL) cholesterol, sometimes called “bad cholesterol.” These ...
A contraindication to taking an angiotensin receptor blocker (ARB) (e.g., cirrhosis, prior angioedema with angiotensin-converting enzyme inhibitor (ACE-I) ...
Mishra S, Persons PA, Bersoux S. Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period? Cleve Clin J Med. 2025 Apr 1 ...
Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity. 1997 Dec; 7 (6):821 ...
... receptor antagonists or proton pump inhibitors; Known active infection with human immunodeficiency virus (HIV), hepatitis B virus, or hepatitis C; Autologous ...
Use of chronic medications (statins, anti-inflammatory drugs, angiotensin II receptor blockers (ARBs) and/or angiotensin-converting enzyme (ACE) inhibitors).
... receptor 2 (FGFR2). Ponatinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. A Phase I, Multi ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.